Dried Soup Market PESTLE and Porter’s Analysis & Regulatory Landscape, Key Facts, Segmentation, Key Players Analysis and Forecast to 2022

According to Future Market Insights (FMI)’s recently published report, the global dried soup market will soar at a CAGR of 2.6% between 2017 and 2022, to reach a valuation in excess of US$ 2,000 Mn.

Dried soup is also referred to as instant soup mix that comprise of dehydrated ingredients such as grains, vegetables, legumes, and meat among others. There a number of procedures or methods available for dehydration of ingredients, however, freeze drying or slow air drying techniques remain the prominent ones. Dried soup is also gaining momentum owing to its high nutritional offerings in oppose to other varieties of instant or ready-to-eat soup available in the market.

Request a Report Sample to Gain Comprehensive Market Insights@
https://www.futuremarketinsights.com/reports/sample/rep-gb-5066

Additional factors such as changing consumer preference, rising disposable income and changing lifestyle is further influencing the pattern of consumption of various convenience food items including dried food. Increased reliance on such easy-to-make and reasonably healthy food items is expected to drive the global sales of dried soup over the next couple of years.

Introduction of new flavours and implementation of creative promotional strategies by brands are proving to be quite effective in driving the sales of their products. Some of the new and innovative packaging concepts are successfully drawing consumers’ attention. New packaging styles are playing an important role in influencing the consumers’ mind set, making them more curious about the product. Manufacturers usually use pouches, cup or boxes to pack dried soup and try to create designs that can appeal to consumers.

In addition, growing popularity of the convenience food and increasing consciousness about healthy food among consumers is likely to make a positive impact on the global market for dried soup during the forecast period. The arrival of dried soup that has zero gluten content and are prepared using organic ingredients is anticipated to support the growth of the market. However, the artificial flavouring and preservatives added to dried soup may increase blood pressure and blood sugar levels, which remains a major issue for most manufacturers.

Additional Highlights of the Report Include: 

  • FMI’s report reveals that the Europe will continue to be the most lucrative market for dried soup during the assessment period. Europe currently commands for the largest revenues share of the global market in terms of revenue. This is primarily attributed to the robust consumption of dried soup in the regions.

Moreover, a number of hotels, bars and restaurants in Europe include various dried soup dishes in their menu. Meanwhile, North America and Asia-Pacific excluding Japan (APEJ) regions will also remain important markets for dried soup over 2022.

  • On the basis of product type, the dehydrated dried soups segment will retain its top position over 2022. This segment currently represents over 84% market share in terms of revenue and the figure is likely to witness a slight uptick by the end of the forecast period.

Talk to Analyst, About this Report@
https://www.futuremarketinsights.com/ask-question/rep-gb-5066

  • On the basis of packaging, the pouches segment is expected to remain highly attractive through the forecast period. Currently, the segment commands for close to 43% revenue share of the market and likely to remain dominant in 2017 and beyond. By 2022-end, the pouches segment is expected to surpass a market valuation of US$ 900 Mn.

Competitive Landscape

In order to gain a competitive edge, leading companies operating in the global market for dried soup are actively focusing on introduction of new and unique dried soup flavours that have higher food value. General Mills, Inc., Campbell Soup Co., Nestlé S.A., B&G Foods, Inc., Greencore Group Plc. Unilever Plc, Associated British Foods, The Kraft Heinz Company, Baxter’s Food Group, and Nissin Foods Holdings Co. Ltd. are some of well-known companies that manufacture dried soup.

Ask for Free Customization of Report@
https://www.futuremarketinsights.com/customization-available/rep-gb-5066

Market Taxonomy Product :

  • Dehydrated Dried Soups
  • Instant Dried Soups

Packaging :

  • Pouches
  • Cups
  • Boxes

Sales Channel :

  • HORECA
  • Modern Trade
  • Convenience Stores
  • Online Stores
  • Others

Read Some other Report:

https://pressreader.com/article/6755635681121184

https://thegameoflife-de.mn.co/posts/25792741?utm_source=manual

https://the-trifecta-network.mn.co/posts/25792749?utm_source=manual

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the year.

Contact Us:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers-
Dubai
​United Arab Emirates
For Sales Queries: sales@futuremarketinsights.com
Browse All Report: https://www.futuremarketinsights.com/reports

LinkedInTwitterBlogs 

Oryzenin Market Demand, Leading Challenges for Manufacturers, Key Facts, Product Type Analysis & Forecast-2022

Future Market Insights (FMI) has published a new report, which is titled, “Oryzenin Market: North America to Dominate the Global Oryzenin Market in Terms of Revenue: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022).” According to the report, oryzenin is a much better alternative as compared to barley, wheat, and rye as it does not lead to any kind of allergies or disorders such as the celiac disease and this is a key factor boosting its demand worldwide.

Consumers seeking lactose free and gluten free source of protein are extensively demanding oryzenin, as it is safe and does not cause any disorders relating to digestion. As per FMI, the global oryzenin market will reach an evaluation of US$12 mn by 2022, expanding it robust CAGR of 7.3% between 2017 and 2022

For more Insights, Download the Comprehensive Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-4906

The market for oryzenin is also expected to be boosted by the increasing incidences of gastrointestinal diseases, celiac disease, and irritable bowel syndrome. As the demand for rice protein is increasing on account of its functional properties, the demand for oryzenin will also grow. This is because oryzenin is a glutelin type which is found in the seeds of rice. Some of the other factors impacting the growth of this market include the low cost of producing rice proteins, high protein content, and high gelling properties.

On the basis of geography, the global oryzenin​ market is segmented into Asia Pacific, Europe, North America, and the Rest of the World. Of these, it is estimated that North America will emerge as the most lucrative regional market for oryzenin and expand at a healthy CAGR of 9% between 2017 and 2022. By product type, it is estimated that the isolate segment will lead in the market and expand at a healthy 8.3% CAGR from 2017 to 2022. This segment is also estimated to gain the highest BPS by the end of the forecast period. The report also states that the concentrates segment will exhibit high growth potential in the years to come and exhibit a remarkable CAGR throughout the forecast period.

All these aforementioned factors are the reasons behind the extensive use of oryzenin in the food and beverage industry. The increasing health awareness, use as an enhancer for boosting nutritional value in food products, and growing use in sports nutrition will spur the growth of this market worldwide.

For Getting Your Queries Solve Click@
https://www.futuremarketinsights.com/ask-question/rep-gb-4906

On the basis of form, the dry segment is witnessing high growth rate exhibiting an 8.8% CAGR from 2017 to 2022. The drive segment is estimated to gain the highest VPS by the end of the forecast period. On the other hand, the liquid segment holds high share in the market as compared to the dry segment and this trend is estimated to continue for the rest of the office period.

On the basis of application, the bakery and confectionery segment has witnessed the highest growth rate for oryzenin, closely followed by the sports and nutrition segment. The sports and nutrition segment is estimated to gain high BPS in the years to come. In fact the sports and nutrition segment is not only leading currently but is estimated to continue to do so in terms of revenue through 2022.

The report profiles leading players within the global oryzenin market for the purpose of study. These players are:

  • Kerry Group PLC
  • Aidp Inc.
  • Shenzhen Beike Biotechnology Co. Ltd.
  • BENEO GmbH
  • Axiom Foods, Inc.
  • Ribus, Inc.
  • Golden Grain Group Limited
  • Rice bran Technologies, Inc.
  • Bioway (Xi’An) Organic Ingredients Co., Ltd. and The Green Labs LLC.

Read Some other Report:

https://medium.com/@abhinay_30028/the-global-nutraceuticals-market-is-set-to-witness-growth-at-a-cagr-of-12-9-a55d2fe3e8ed

https://writeablog.net/r1agfdoyte

https://www.spoke.com/topics/nutraceuticals-market-latest-research-industry-analysis-driver-trends-business-overview-key-size-value-demand-and-forecast-2022-2032-62ecbd8af892536dc0004f38

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the year.

Contact Us:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers-
Dubai
​United Arab Emirates
For Sales Queries: sales@futuremarketinsights.com
Browse All Report: https://www.futuremarketinsights.com/reports

LinkedInTwitterBlogs `

Specialty Food Ingredients Market Top Country Data, Key Facts, Revenue Forecast and Volume Forecast with Company Ranking-2022

Besides providing benefits in the form of extended shelf-life of a number of processed food products, specialty food ingredients also enhance qualities such as taste, texture, and flavor. Moreover, their addition to food products help reduce downstream losses owing to their impact on storage and processing of foods.

These factors, along with the advent of several innovative technologies, such as the technology for decaffeination of coffee beans, has also increased the popularity of the global specialty food ingredients market.

For More Insights, Get Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-4800

The massive rise in demand for convenience foods from across the globe, mounting population in urban settings, and rising purchasing power of the global population are collectively driving the global demand for specialty food ingredients, observes a recent market research report published by Future Market Insights.

The report states that the market will expand at a steady pace over the period between 2017 and 2022, rising to a revenue opportunity of nearly US$85,000 mn by the end of 2022.

The report segments the global specialty food ingredients market on the basis of criteria such as specialty sensory ingredient, specialty fundamental ingredient, application, and geography.

In terms of specialty sensory ingredient, the market has been segmented into varieties such as emulsifiers, enzymes, colorants, and flavors. Of these, the segment of enzymes is likely to remain the most promising segment over the report’s forecast period, surpassing a revenue valuation of US$20,000 mn by 2022. Demand for colorants and emulsifiers is expected to see close competition in terms of revenue contribution to the global market throughout the report’s forecast period. The segment of flavors will exhibit expansion at the most promising pace over the report’s forecast period.

In terms of specialty functional ingredient, the report segments the market into vitamins, antioxidants, minerals, and preservatives of these, the segment of preservatives is expected to record a highly promising growth pace over the report’s forecast period. However, the segment of minerals, which is presently the most consumed functional ingredient in the global market, will continue to exhibit a promising pace of expansion over the report’s forecast period as well.

The sales of vitamins could dwindle and the segment is expected to record the lowest CAGR of all the other segments over the forecast period.

Request Customize Report@
https://www.futuremarketinsights.com/customization-available/rep-gb-4800

The key application areas of specialty food ingredients examined in the report include beverages, bakery and confectioneries, dairy and frozen foods, functional foods, beverages and dietary supplements, meat products, oils and fats, and sauces, savory snacks, and dressings and condiments. Of these, the segment of bakery and confectionaries is expected to retain its position as the largest shareholder in the global market, followed by the segment of convenience foods.

However, the demand from the meat products and functional food, beverages and dietary supplements segments will record a higher pace of expansion over the report’s forecast period.

From a geographical standpoint, the market for specialty food ingredients in North America is slated to emerge as the one with the most lucrative growth opportunities over the report’s forecast period. The North America market for specialty food products is expected to rise to a valuation of nearly US$24,000 mn by the end of 2022.

Some of the leading players operating in the global specialty food ingredients market are E. I. Dupont De Nemours and Company, Advanced Food Systems Inc., Cargill Inc., Ingredion Incorporated, Specialty Commodities, Kerry Group Plc., Koninklijke DSM N.V., Sensient Technologies Corporation, Cambrian Solutions Inc., and Tate & Lyle.

Specialty Sensory Ingredients

  • Enzymes
  • Emulsifiers
  • Flavors
  • Colorants
  • Others

Specialty Functional Ingredients

  • Vitamins
  • Minerals
  • Antioxidants
  • Preservatives
  • Others

Ask an Expert about this Report@
https://www.futuremarketinsights.com/ask-question/rep-gb-4800

Application

  • Bakery & Confectioneries
  • Beverages
  • Dairy & Frozen Foods
  • Convenience Food
  • Meat Products
  • Functional Foods/ Beverages/ Dietary Supplements
  • Oils & Fats
  • Others (includes Savory snacks, Sauces, Dressings & Condiments )

Read Some other Report:

https://researchblogs397482055.wordpress.com/2022/08/05/nutraceuticals-market-development-status-competition-analysis-type-and-application-2022-2032/

https://abhinayfmi.blogspot.com/2022/08/nutraceuticals-market-outlook-current.html

https://www.tumblr.com/blog/view/futuremarketinsightsposts/691726364509863936?source=share

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the year.

Contact Us:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers-
Dubai
​United Arab Emirates
For Sales Queries: sales@futuremarketinsights.com
Browse All Report: https://www.futuremarketinsights.com/reports

LinkedInTwitterBlogs 

Medical Nitroglycerin Sprays Market Will Generate Booming Growth Opportunities to 2030

According to Future Market Insights (FMI), the global medical nitroglycerin sprays market was valued at US$ 94.4 Mn in 2019, and is expected to register a CAGR of 4.2% during the forecast period, reaching US$ 147.3 Mn by the end of 2030.

Key Takeaways from the Medical Nitroglycerin Sprays Study

  • North America touted to retain market hegemony, capturing over two-fifths of the revenue share
  • Prophylaxis of angina pectoris to remain the dominant segment, expanding steadily at 4.1% CAGR from 2022-2030
  • By distribution channel, online pharmacy sales are poised to witness credible expansion owing to the pandemic and deepening digital literacy
  • 90 metered sprays/bottle dose capacity to remain the most preferred option, registering an index of 1.4
  • Global medical nitroglycerin sprays market is likely to expand steadily, registering a CAGR of 4.2%

Key Drivers and Restraints of Global Medical Nitroglycerin Spray Market

Medical nitroglycerin is available in multiple dosage forms such as sublingual tables, sprays, in-vitro and patches, and ointments. For instance, nitroglycerin sprays are available in different capacities, ranging between 60 doses per bottle to 230 dose per bottle. Availability of nitroglycerin spray in a wide range of dosage forms and capacities is projected to fuel the global market during the forecast period.

Nitroglycerin spray is inexpensive and hence affordable. It also offers better therapeutic effects as compared to that offered by other medications. Furthermore, it has minimum side-effects as compared to that of conventional drugs. These factors are estimated to drive the nitroglycerin spray market in the next few years.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12620

ccording to the World Health Organization (WHO), cardiovascular disease accounts for nearly 17.9 million deaths every year, which is estimated to contribute to 31% of all global deaths. A rise in the number of people suffering from cardiovascular diseases can be attributed to sedentary lifestyle along with smoking, tobacco & alcohol consumption, and unhealthy diet. Hence, a rise in prevalence of cardiovascular diseases is projected to fuel the global market during the forecast period.

According to the World Health Organization (WHO), the population of people aged 60 years and above is projected to rise from 900 million in 2015 to 2 billion in 2050. Usually, the geriatric population is at high risk of coronary vascular disease. Hence, an increase in the geriatric population is anticipated to boost the global nitroglycerin spray market.

Market segmentation

Medical Nitroglycerin Sprays Market by Application:

  • Prophylaxis of Angina Pectoris
  • Acute Relief of Attack (Treatment)

Medical Nitroglycerin Sprays Market by Dose Capacity:

  • 60 Metered Sprays/Bottles
  • 90 Metered Sprays/Bottles
  • 200 Metered Sprays/Bottles
  • 230 Metered Sprays/Bottles

Medical Nitroglycerin Sprays Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Medical Nitroglycerin Sprays Market by Region:

  • North America Medical Nitroglycerin Sprays Market
  • Latin America Medical Nitroglycerin Sprays Market
  • Europe Medical Nitroglycerin Sprays Market
  • East Asia Medical Nitroglycerin Sprays Market
  • South Asia & Pacific Medical Nitroglycerin Sprays Market
  • Middle East & Africa (MEA) Medical Nitroglycerin Sprays Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12620

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Key Inclusion & Exclusion

  1. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

  1. Key Success Factors

4.1. Prevalence & Patient Share

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12620

Read Related Reports:

https://network-759413.mn.co/posts/25865162?utm_source=manual

https://shangwich.mn.co/posts/25865165?utm_source=manual

https://stemfemmes.mn.co/posts/25865166?utm_source=manual

https://careero.mn.co/posts/25865169?utm_source=manual

https://thegameoflife-de.mn.co/posts/25865170?utm_source=manual

https://network-66643.mn.co/posts/25865173?utm_source=manual

https://beyondher.mn.co/posts/25865175?utm_source=manual

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Ankylosing Spondylitis Treatment Market Trends, Demand Growth Revenue Analysis Report to 2030

The global ankylosing spondylitis treatment market will continue to witness steady growth, driven by a slew of myriad, yet interconnected factors. A new report by ESOMAR-certified market research firm, Future Market Insights, offers incisive insights on key factors that will influence growth through 2030.

According to FMI’s report, the options for treatment include disease-modifying anti-rheumatic drugs (methotrexate), nonsteroidal anti-inflammatory drugs (naproxen, ibuprofen, celecoxib, meloxicam, and diclofenac), biologics (certolizumab pegol, secukinumab, infliximab), and biosimilars.

Key Takeaways from Ankylosing Spondylitis Treatment Market Study

  • Nonsteroidal anti-inflammatory drugs lead the market as they are looked upon as the first line of treatment for ankylosing spondylitis
  • Oral route of administration holds the largest market share due to simplicity of consumption.
  • By age group, “adults” contribute to majority of revenue generation as ankylosing spondylitis usually gets initiated in adulthood.
  • North America, led by the US, holds the highest market share due to well-established healthcare infrastructure, high incidences of ankylosing spondylitis, and innovations in pharmaceutical industry.

Ankylosing Spondylitis Treatment Market Landscape

The major players in the ankylosing spondylitis market include Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Novartis AG, Amgen, Centocor, Abbott, Eisai, and Pfizer.

As per the Oxford University Press, around 1% of the US population, 1.3-1.56 Mn European population, and 4.63-4.98 Mn population in the Asia Pacific are affected by ankylosing spondylitis. Also, the market is witnessing massive investment on the part of research to table new formulations.

Inorganic growth parameters are also contributing a great deal to the growth of ankylosing spondylitis treatment market. For instance – Novartis AG, in Jan 2019, entered into a collaboration with TrialSpark with an objective of increasing patients’ access to the clinical trials. The enrollment timeline is expected to shorten, thereby speeding up development of novel therapies.

In Oct 2019, the European Commission approved Cosentyx to treat non-radiographic axial spondyloarthritis. The next step includes submission of label update application to US FDA and post approval, the market is expected to grow substantially.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12345

“Agreement” is the other strategy used. For instance – Izana Bioscience, in Dec 2017, entered into a global license agreement with Takeda Pharmaceutical Company for manufacturing, commercializing, and developing Namilumab to treat ankylosing spondylitis.

Also, Zydus Cadila, in Nov 2017, launched Adalimumab’s biosimilar in India. It has been used to treat ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis.

Initiatives like these have been giving impetus to the ankylosing spondylitis market and the status quo is likely to remain the same in the forecast period.

Key Segments:

Drug Class

  • Nonsteroidal Anti-inflammatory Drugs
  • Anti-Inflammatory Drugs
  • Immunosuppressive Drugs
  • TNF Blockers
  • JAK Inhibitors
  • Steroids
  • Biologics
  • Others

Route of Administration

  • Parenteral
  • Oral

Application

  • Adults
  • Juveniles

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12345

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

  1. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

  1. Key Success Factors

4.1. Product Adoption / Usage Analysis

4.2. Product USPs / Features

4.3. Key Promotional Strategies

  1. Global Ankylosing spondylitis Treatment Market – Pricing Analysis

5.1. Regional Pricing Analysis By Drug Class

5.2. Pricing Break-up

5.2.1. Manufacturer Level Pricing

5.2.2. Distributor Level Pricing

5.3. Global Average Pricing Analysis Benchmark

Want More Insights?

The global ankylosing spondylitis treatment market is elaborated on the basis of drug class (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, and Others), route of administration (parenteral, oral), application (Adults, juvenile), and geography (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA).

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12345

Read Related Reports:

https://acatpg.mn.co/posts/25865150?utm_source=manual

https://globalsocials.mn.co/posts/25865152?utm_source=manual

https://faceblox.mn.co/posts/25865153?utm_source=manual

https://drujrake.mn.co/posts/25865155?utm_source=manual

https://domain.tribe.so/post/nerve-monitoring-devices-market-analysis-size-share-growth-trends-and-forec–62f0e30d40e80f3ca4445c0a

https://cipmo-system.mn.co/posts/25865159?utm_source=manual

https://globalsocials.mn.co/posts/25865161?utm_source=manual

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Eye Infections Treatment Market By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2030

Increasing prevalence of eye infections due to ocular surgical procedures is primarily shaping eye infection treatment market. A recent Future Market Insights (FMI) report forecasts that even though the eye infection treatment market would continue to experience a downtrend throughout 2022 due to COVId-19 pandemic, revenues would reach US$ 10 Bn by the end of 2030. Post-operative ocular infections remain among the most common eye infection types, says the FMI study.

Rising Caseloads

Caseloads of ocular surgical conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are growing due to sedentary lifestyle habits, and expanding geriatric cohort. According to the US statistics 2021, cataracts affect over 24 million Americans aging at least 40 years.

By age 75, about half of the Americans suffer from cataract. Further, diabetic retinopathy affects nearly 7.7 million Americans aging at least 40 years. In similar fashion, there were 48,229 corneal transplants performed in the US in 2015.

Demand for eye infection treatment will continue to receive a strong impetus from increasing awareness about different eye infection types and availability of treatment, further complemented by technological advancements on ophthalmology.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1300

Key Takeaways of Eye Infection Treatment Market Study

  • Antibiotics would contribute over 55% revenue share in the eye infection treatment market owing to their use in treating primary eye infections and post-surgical eye infections.
  • Eye drop sales capture over 60% market share in the eye infection treatment market.
  • Conjunctivitis would account for a third of eye infection treatment demand through 2030.
  • Bacterial infections continue to account for over 3/5th market share.
  • Hospitals and retail pharmacies collectively generate over 70% total returns to shareholders.
  • Increasing rate of eye surgeries and rising usage of contact lenses continue to push North American market. European market would be upheld by the expanding geriatric pool.

Demand for Eye Infection Drugs to Slump Amidst COVID-19 Pandemic

The coronavirus (COVID-19) pandemic has resulted in widened gap between supply and demand of eye infection treatments. As such, it has significantly reduced ocular surgery rate for short-term basis and, in turn, post-operative eye infections.

According to World Health Organization (WHO), national healthcare resources redirection and utilization to contain COVID-19 pandemic is expected to delay and reschedule the treatment of non-critical healthcare conditions for brief period, including eye care services, and ocular surgeries.

Development and Licensing Deals with Multiple Commercialization Partners

Technology developers are laying greater emphasis on developing of novel ophthalmic formulation technologies and engaging with commercialization partners with licensing-out proprietary ophthalmic technologies.

For instance, Nicox S.A. has licensed out ZERVIATE (cetirizine ophthalmic solution) 0.24% to Eyevance Pharmaceuticals LLC for commercialization of ZERVIATE in the US. ZERVIATE is the first topical ocular formulation of antihistamine cetirizine approved for treatment of ocular itching associated with allergic conjunctivitis. In addition, Ocumension Therapeutics is responsible for all development and commercialization activities in Chinese market for ZERVIATE.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-1300

Know More About FMI’s Eye Infection Treatment Market Study

Eye infection treatment market, a new study from Future Market Insights, opines on eye infections treatment from 2015 – 2021 and presents demand projections from 2022 – 2030 on the basis of; drug class (antibiotics, antivirals, antifungals, antihistamines, corticosteroids, and glucocorticoids), dosage form (tablet, capsule, ophthalmic ointment, and eye drops), indication (conjunctivitis, keratitis, endophthalmitis, blepharitis, stye or sty (hordeolum), uveitis, cellulitis, and ocular herpes), causative agent (virus, bacteria, fungus, and allergens) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and drug stores) across seven prominent regions.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Read Related Reports:

https://theastuteparent.tribe.so/post/orthopedic-prosthetic-devices-market-size-analysis-share-research-business—62f0e131b71e41a02c66c3ab

https://immigrationsociety.tribe.so/post/orthopedic-prosthetic-devices-market-revenue-future-growth-trends-top-key-p–62f0e0908e6daf54dee4967a

https://medium.com/@shubham_62155/nerve-monitoring-devices-market-revenue-future-growth-trends-top-key-players-business-591c52a8c40

https://flipboard.com/@shubhamchou2022/nerve-monitoring-devices-market-size-share-forecasts-analysis-company-profile-thrhhe01y

https://sedate-decade-bae.notion.site/Nerve-Monitoring-Devices-Market-Share-Demand-Top-Players-Industry-Size-Future-Growth-By-2032-b5d1e1a5fd86440f9ebeb42fba437c14

https://hackmd.io/@ShubhamChougale/r1sU-PRp9

https://fromfostercaretoceo.mn.co/posts/25865149?utm_source=manual

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Skin Tears Treatment Market Overview, High Growth Opportunities, Segmentation, Trends By 2022-2029

Driven by promotional and educational programs conducted for increased awareness, skin tears treatment market is set to expand 1.4X during 2022 – 2029. Currently representing a US$ 446.2 Mn market, the global skin tears treatment landscape majorly relies on awareness through educational programs, for improved product sales.

Manufacturers of skin tear treatment products are thus focusing on rising awareness levels about wound management through educational programs. Some manufacturers offer product selection criteria, whereas some companies provide these products along with the educational materials.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-8505

Key Takeaways

  • The U.S. is expected to be the prominent region in the skin tears treatment market primarily owing to increasing product adoption rate, rising awareness programs, presence of key players, and strong support from regulatory bodies in the country.
  • Most manufactures focus their efforts towards increasing awareness and educate healthcare professionals towards the importance and use of skin tears treatment products.
  • New skin tears treatment products such as hyaluronic acid wound devices and 2-Octyl Cyanoacrolate topical bandages are expected to gain more traction during the forecast period.
  • Factors such as less awareness, dearth of skilled professionals for identifying and treating skin tears affect the adoption rate of products, thereby hindering market growth.
  • Growing demand for advanced wound care in long-term care settings is expected to drive market growth.
  • Increasing adoption of skin tear treatment products in long-term care settings in the U.S., Canada, Germany, and Japan will particularly assist the growth of skin tears treatment market.

     What Are the Winning Imperatives?

  • Some of the key players offering skin tears treatment products include, 3M Health Care, Smith and Nephew Plc, ConvaTec Group Plc, Mölnlycke Health Care AB, Hollister Inc, BSN Medical GmbH (Essity AB), and Coloplast A/S.
  • The skin tears treatment market is a consolidated market with top four players accounting for 70% of the market share.
  • While most companies are working towards expanding their product reach, some companies are focused towards developing new products to penetrate and maintain a foothold in the market.
    • For instance, Medline Industries is focused towards developing a stronger distribution network in the U.S. Manufacturers such as ConvaTec Group PLC., Mölnlycke Health Care, and Coloplast A/S have launched new products for skin tears treatment.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-8505

Read Related Reports:

https://community-specialists.tribe.so/post/orthopedic-prosthetic-devices-market-share-growing-rapidly-with-recent-tren–62f0e08859bf0dbc84b5daad

https://speaknow.tribe.so/post/orthopedic-prosthetic-devices-market-business-opportunities-top-manufacture–62f0e088fec06d02d853c85b

https://howtolive.tribe.so/post/orthopedic-prosthetic-devices-market-analysis-company-profiles-competitive—62f0e08935655f6e6301a76f

https://mayokodozite.tribe.so/post/orthopedic-prosthetic-devices-market-assessment-opportunity-forecast-till-2–62f0e08a4b1f2e7135a3e4d0

https://rigenrin.tribe.so/post/orthopedic-prosthetic-devices-market-global-industry-size-strategies-trends–62f0e08b35655f04c701a771

https://sharequant.tribe.so/post/the-orthopedic-prosthetic-devices-market-is-projected-to-register-a-cagr-of–62f0e08b85ff538a7adce5da

https://itsthesa.tribe.so/post/orthopedic-prosthetic-devices-market-business-opportunities-top-manufacture–62f0e08c35655fe79801a773

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Lip Fillers Market Segmentation by Revenue, Present & Future Scenario To 2028

Lip Fillers Market is currently valued at around US$ 1.3 Bn, and is anticipated to progress at a CAGR of 3.8% to reach US$ 1.63 Bn by 2028, finds the new market intelligence study by Future Market Insights (FMI). ALLERGAN, Galderma Laboratories, and Merz Pharma GmbH & Co. KGaA retain their lead as the top three companies in the lip fillers market space, followed by several other market players progressing up along the growth ladder with new product launches in the pipeline.

The FMI analyst finds that North America continues to be the leading market for lip fillers, with the US estimated to command ~ 94.5% of the regional market growth. As per the recent studies, in 2021, nearly 18 million people underwent surgical and minimally-invasive cosmetic procedures in the United States in 2021.

This is a clear indication of the fact cosmetic surgical procedures in North America, which are on a significant rise over the past 5-6 years, are further set for a massive growth in the future.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-10271

The FMI analyst is of the opinion that social media remains one of the biggest factors encouraging consumers to opt for lip fillers. With the selfie culture penetrating across consumer bases from different regions, lip fillers have become a highly feasible and readily accessible option for the consumers to get the ‘picture-ready’ appearance.

However, potential risks associated with the use of lip fillers, including temporary bruises and permanent tissue spoilage, continue to daunt consumer confidence and, calling for safe and reliable variants to make their mark in the lip fillers market.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-10271

East Asia Promises Untapped Corners for the Market Players to Explore

Millennials represent a very attractive category for lip filler manufacturers to focus on, given that the ones who are unhappy or self-conscious about their facial aesthetics are opting for these procedures to get appealing makeovers.

The FMI analyst finds that a wide-range of safe and effective options will remain the key revenue level for companies active in the lip fillers market. In addition, these companies are also drawing upon the mega-trend of personalization via tailor-made lip filler solutions, which will further help them life their profit pools.

FMI’s research study opines that lip augmentation with hyaluronic acid-based solutions will remain the most frequently requested procedures in aesthetic practices. This can be gauged by the fact that in 2022, hyaluronic acid will surpass Poly-L-Lactic Acid to account of ~ 94% of the global lip fillers-derived business value.

Read Related Reports:

https://bipolarjungle.mn.co/posts/25864838?utm_source=manual

https://community.telegramfxcopier.io/post/orthopedic-prosthetic-devices-market-size-growth-factors-top-leaders-trends–62f0e07c59bf0d2b70b5daa7

https://www.launchora.com/story/orthopedic-pros-tic-devices-market-overview-by-s

https://kgn.tribe.so/post/orthopedic-prosthetic-devices-market-analysis-by-future-demand-top-players—62f0e084ac0a7b91015e7ded

https://aftrword.tribe.so/post/orthopedic-prosthetic-devices-market-share-size-global-industry-analysis-ke–62f0e08535655f127201a76a

https://aftrword.tribe.so/post/orthopedic-prosthetic-devices-market-growth-analysis-size-trends-emerging-f–62f0e08535655f81f201a76c

https://apsaraofindia.tribe.so/post/orthopedic-prosthetic-devices-market-movements-by-trend-analysis-growth-sta–62f0e08685ff530bd0dce5d6

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

HDL Cholesterol Kits Market Size, Strategies and Opportunities Forecast 2022-29

The growth of the HDL cholesterol kits market can be attributed to the increasing prevalence of atherosclerosis due to high cholesterol level, which favours the demand for cholesterol testing. According to the latest research by FMI, the global HDL cholesterol kits market is expected to be valued at US$ 786.2 Mn by the end of 2029. The HDL cholesterol kits market is expected to expand at a CAGR of 4.8% during the forecast period 2022-2029.

The increasing incidence of obesity and hyperlipidaemia among people is boosting the need for cholesterol testing, which is driving the growth of the HDL cholesterol kits market. The prevalence of obesity has increased from 33.7% in 2007-2008 to 39.7% in 2015-2016 among adults in the U.S. The increasing prevalence of obesity also increases the risk of cardiovascular disorders, high blood pressure, and hyperlipidaemia. Moreover, the prevalence of hyperlipidaemia is high among the obese population. Nearly 60-70% of patients suffering from obesity have hyperlipidaemia. Other factors, such as growing awareness programs for cholesterol testing and growing cholesterol testing among diabetic patients, are also propelling the growth of the HDL cholesterol kits market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-9842

Rise of ‘Regular Health Check’ Trend Uplifts Prospects in East Asia

Low awareness in middle- and low-income countries about cholesterol testing and other healthcare testing are also among the major factors that are expected to hamper the growth of the HDL cholesterol kits market. There is low awareness about diseases such as dyslipidaemia and hypercholesterolemia in middle-income countries and rural areas. Moreover, the chances of errors and inaccuracy in HDL cholesterol testing methods, such HDL cholesterol precipitating method, are among factors expected to restrain the growth of the HDL cholesterol kits market.

The North America HDL cholesterol kits market gain a maximum value share in 2018. However, the East Asia HDL cholesterol kits market expected to witness prominent growth owing to the higher demand for cholesterol testing in countries such as China and Japan. Developing countries, such as China and India, represent a significant growth rate in the HDL cholesterol kits market due to the growing adoption of regular healthcare testing. The Middle East & Africa HDL cholesterol kits market is expected to witness a sluggish growth rate as compared to other regions.

The global HDL cholesterol kits market has been studied based on the product type and end user. Based on the product type, the HDL cholesterol kits market has been segmented into HDL cholesterol precipitating reagent kit, HDL cholesterol direct reagent kit, and HDL and LDL/VLDL assay kit. The HDL and LDL/VLDL assay kit product type segment is expected to hold a prominent share in the global HDL cholesterol kits market. Based on end user, the HDL cholesterol kits market has been segmented into hospitals, clinics, and diagnostic laboratories. In terms of revenue, the hospitals segment of the HDL cholesterol kits market was a significant market for HDL cholesterol kits in 2018.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-9842

Partnerships and Acquisitions Governing the Competition Landscape

Some of the key players operating in the HDL cholesterol kits market are Diazyme Laboratories, Inc., Randox Laboratories Limited, Fujifilm Holding Corporation, Thermo Fisher Scientific, Abcam plc., Merck KGaA, Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), PerkinElmer, Inc., and Hoffmann-La Roche Ltd.

Players in the HDL cholesterol kits market are focusing on partnerships and acquisitions with regional and global players to increase their sales worldwide. For instance, through the acquisition of Wako Pure Chemical, Fujifilm Holding Corporation expand its presence in the life science and chemical sectors. The manufacturers of HDL cholesterol kits are focusing on the expansion of their presence in key markets such as the Asia Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities. The manufacturers of HDL cholesterol kits are also focusing on the development of point-of-care testing as it is more helpful and convenient for making quicker decisions. Moreover, HDL cholesterol kits industry stakeholders are focusing on the addition of direct reagent kits in their product portfolios.

Read Related Reports:

https://careero.mn.co/posts/25864828?utm_source=manual

https://thegameoflife-de.mn.co/posts/25864829?utm_source=manual

https://network-66643.mn.co/posts/25864831?utm_source=manual

https://beyondher.mn.co/posts/25864835?utm_source=manual

https://synkretic.mn.co/posts/25864836?utm_source=manual

https://synkretic.mn.co/posts/25864836?utm_source=manual

https://wecanchat.mn.co/posts/25864837?utm_source=manual

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Mucus Clearance Devices Market Analysis by Type, Application, Growth, Demand, Status, and Forecast from 2022 to 2028

Sales in the global Mucus Clearance Devices Market are slated to top US$ 595.2 Mn in 2022. Expanding at a healthy 6.1% CAGR, the market size is projected to total US$ 847.0 Mn by 2028. The report has tracked Mucus Clearance Devices Market for a decade-old period of projection, 2022-2028.

According to a recent market research study of Future Market Insights (FMI), more than 5 million units of mucus clearance devices were sold in 2021. The sales will reportedly increase by a robust 7.7% in 2022, as per the Y-o-Y growth calculated in the report. A majority of the demand for mucus clearance devices is accounted by home care settings, followed by hospitals.

On other hand, stringent regulatory guideline by FDA for the approval of medical devices is likely to act as roadblock for the mucus clearance devices market. In addition, lack of awareness about the symptoms of cystic fibrosis and COPD in developing economies is another factor that is likely to hamper the growth of the mucus clearance devices market. Furthermore, the treatment rate for respiratory disorders is much lesser in low- and middle-income countries, which is also hampering the growth of the mucus clearance devices market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-9416

North America is the most prominent region in the global mucus clearance devices market, with over 2/5th of the total market volume. North America’s market for mucus clearance devices is followed by Europe and East Asia, and the report points to attractive opportunities residing in India, Brazil, and South Africa.

Key Players in Mucus Clearance Devices Market Focusing on Online Distribution Channels

Leading distributers and suppliers operating in the global mucus clearance devices market are eyeing opportunities in the E-commerce sector. Online introduction and sales of innovative mucus clearance devices is being practiced by several companies to minimize costs associated with supply, distribution, and operation. Online availability also tends to attract a wider consumer base as it enables products comparison, according to research.

The rising focus of the leading medical device manufactures to launch novel mucus clearance devices such as SmartVest is expected to lead to the robust growth of the mucus clearance devices market. Smart mucus clearance devices that are being developed on a similar line of SmartVest have the smartphone-connectivity feature that allows doctors and respective hospitals to have ready access to real-time data, which can be further provided to telemedicine service providers. According to the report, such advanced technology enabled innovations will play a crucial role in boosting demand for mucus clearance devices in the near future.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-9416

Hill-Rom Inc., the global leader in mucus clearance devices landscape, currently represents an approximate 35% share in the market revenue. The report also profiles several other prominent players competing in the mucus clearance devices market, which include Allergan plc, Koninklijke Philips N.V., Respiratory Technologies, Inc., Smiths Medical, Electromed, Inc., Monaghan Medical Corporation, Dr. Burton Healthcare LLC, Actegy Limited, Westmed, Inc., International Biophysics Corporation, Thayer Medical, R. Cegla GmbH & Co. KG, Medical Acoustics LLC, VORTRAN Medical, and PARI Medical Holding GmbH.

Read Related Reports:

https://drujrake.mn.co/posts/25864816?utm_source=manual

https://domain.tribe.so/post/orthopedic-prosthetic-devices-market-share-development-forecast-to-2032-the–62f0e0620535fe1daf231283

https://cipmo-system.mn.co/posts/25864817?utm_source=manual

https://globalsocials.mn.co/posts/25864819?utm_source=manual

https://network-759413.mn.co/posts/25864824?utm_source=manual

https://shangwich.mn.co/posts/25864825?utm_source=manual

https://stemfemmes.mn.co/posts/25864827?utm_source=manual

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs